Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptional comparison of in vitro generated human dendritic cells and peripheral blood circulating dendritic cells.

ABSTRACT: Transcriptional comparison of in vitro generated human dendritic cells and peripheral blood circulating dendritic cells.

PROVIDER: PRJNA603654 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10983473_1.fastq.gz	Fastqsanger.gz
	SRR10983473_2.fastq.gz	Fastqsanger.gz
	SRR10983474_1.fastq.gz	Fastqsanger.gz
	SRR10983474_2.fastq.gz	Fastqsanger.gz
	SRR10983475_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 30

Similar Datasets

Transcriptional comparison of in vitro generated human dendritic cells and peripheral blood circulating dendritic cells

Project description:Transcriptional comparison of in vitro generated human dendritic cells and peripheral blood circulating dendritic cells

| PRJNA634561 | ENA

Transcriptional comparison of in vitro generated human dendritic cells and peripheral blood circulating dendritic cells.

Project description:Classical dendritic cells (cDCs) are rare sentinel cells specialized in the regulation of adaptive immunity. Modelling cDC development is both crucial to study cDCs and harness their potential in immunotherapy. Here we present a novel in vitro cDC differentiation protocol using cord blood CD34+ hematopoietic stem and progenitor cells (HSPCs) co-cultured with bone marrow-derived murine mesenchymal cell line (MS5) engineered to co-express human FLT3L, SCF and CXCL12 (MS5_FS12).

2020-03-11 | GSE144435 | GEO

Transcriptional comparison of in vitro generated human dendritic cells and peripheral blood circulating dendritic cells

2020-05-23 | GSE151086 | GEO

Transcriptional comparison of in vitro and in vivo generated human dendritic cells

Project description:Transcriptional comparison of in vitro and in vivo generated human dendritic cells

| PRJNA608278 | ENA

Transcriptional comparison of in vitro and in vivo generated human dendritic cells

Project description:Transcriptional comparison of in vitro and in vivo generated human dendritic cells

| PRJNA634548 | ENA

RNA-seq of circulating inflammatory human cDC2 dendritic cells

Project description:RNA-seq of circulating inflammatory human cDC2 dendritic cells

| PRJNA563353 | ENA

RNA-seq of circulating inflammatory human cDC2 dendritic cells

Project description:Distinct subsets of circulating human cDC2 dendritic cells were sorted based on CD5, CD163 and CD14 expression, including a subset of inflammatory CD5-CD163+CD14+ cells related to DC3s which were expanded in systemic lupus eryhtematosus (SLE) patients and correlated with disease activity.

2019-09-02 | GSE136731 | GEO

Transcriptional comparison of in vitro and in vivo generated human dendritic cells

Project description:Dendritic cells (DC) are antigen presenting cells controlling T cell activation. In human, the diversity, ontogeny and functional capabilities of DC subsets are not fully understood. Here, we identified circulating CD88-CD1c+CD163+ DC (termed as DC3) as an immediate precursor of inflammatory CD88-CD14+CD1c+CD163+FcεRI+ DC. DC3 develop via a specific pathway, independent from the cDC-restricted (CDP) and monocyte-restricted (cMoP) progenitors, and are activated by GM-CSF. As classical DC, but unlike monocytes, DC3 drove the activation of naïve T cells. In vitro, DC3 displayed a distinctive ability to prime CD8+ T cells expressing a tissue-homing signature and the epithelial homing alpha-E integrin (CD103) through transforming growth factor-b (TGF-β) signaling. In vivo, DC3 infiltrated luminal breast cancer primary tumors and DC3 infiltration correlated positively with CD8+CD103+CD69+ tissue-resident memory T cells. Altogether, these findings define DC3 as a lineage of inflammatory DC endowed with a strong potential to regulate tumor immunity.

2020-05-23 | GSE151073 | GEO

Comparison of human plasmacytoid dendritic cells and monocyte-derived dendritic cells

Project description:Comparison of human plasmacytoid dendritic cells and monocyte-derived dendritic cells

| PRJEB66498 | ENA

Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine

Project description:This study is being conducted to determine the efficacy, side effects, and toxicity of an investigational vaccine that consists of tumor-pulsed dendritic cells administered with an immune stimulating drug called interleukin-2 (IL-2). Dendritic cells are immune cells that are obtained from a subject’s blood and are important in the body’s immune response to foreign substances. This study will examine the response of a subject’s immune system after receiving several vaccinations containing their own dendritic cells which have been exposed to dead fragments of their cancer cells in the laboratory. This may result in sensitizing a subject’s dendritic cells to their cancer cells so that their dendritic cells will react with other cells of the immune system and attack the cancer. It has been shown in the laboratory that dendritic cells exposed to cancer cell fragments can provide lymphocytes (a type of white blood cell) with signals they require in order to become fully activated and acquire the ability to kill cancer cells.

| 2017769 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data